SNY Stock — Sanofi

Sanofi (SNY)

Updated October 16, 2026.

SNY is a Stock. its distribution rate is 5.96%, its trailing-12-month yield is 5.96%. Dividend Vision Distribution Safety Score™ is 83/100 (Safe). Total return is 233.1% over the past 24.3 years, 888.8 points behind SPY at 1121.9%.

Sanofi is a multinational pharmaceutical company engaged in researching, developing, manufacturing, and marketing therapeutic solutions across immunology, inflammation, rare diseases, neurology, oncology, and vaccines. The company distributes dividends on an annual basis at a current rate that is moderately elevated for pharmaceutical equities. Sanofi appeals to income-oriented investors seeking exposure to the global pharmaceutical sector alongside regular dividend payments.

SNY performance versus SPY

Price and return data through 2026-10-16.

Total return is 233.1% over the past 24.3 years, 888.8 points behind SPY at 1121.9%. Over the past year its total return — price change plus distributions reinvested — is -14.3%. Its deepest 1-year drawdown was 21.1%.

SNY key facts

Distribution Safety Score™

83 · Safe

Safety-Adjusted Yield

4.95%

Asset type

Stock

Asset class

Equity

Inception date

07/01/2002

Distribution rate

5.96%

Distribution frequency

Annual

Trailing yield

5.96%

5-year average yield

4.02

Last close

$40.61 (stale; as of 2026-10-16)

Market cap

$97,307,138,596

Average volume

4631900.0

Dividend

$2.422

Ex-dividend date

05/04/2026

Payment date

06/03/2026

Beta

0.281

Payout ratio

49.3%

P/E ratio

21.04

Forward P/E

8.5911

EPS

$1.93

How Dividend Vision calculates yield and returns

Distribution rate (5.96%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (5.96%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SNY risks and drawbacks

Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 21.1%.

Who may consider SNY — and who may not

SNY may suit someone looking for a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (SNY pays annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on SNY

• All tickers starting with S

Tagged: Pharmaceutical, Dividend.

Frequently asked questions